Cargando…

Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography

BACKGROUND: Many radio-pharmaceuticals have been used over the years to localize the recurrences in patients with medullary carcinoma thyroid (MCT), including iodine-131-metaiodobenzylguanidine, thallium-201, technitium-99m dimercaptosuccinyl acid [Tc-99m DMSA (V)], Tc-99m methoxyisobutylisonitril,...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnamurthy, Arvind, Kumar, Ramachandran Krishna, Ravishankaran, Praveen, Ramshankar, Vijayalaksmi, Balkis Begum, Ahamed Sultan, Rangarajan, Gomadam Kuppuswamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157187/
https://www.ncbi.nlm.nih.gov/pubmed/25210279
http://dx.doi.org/10.4103/0972-3919.136562
_version_ 1782333828700831744
author Krishnamurthy, Arvind
Kumar, Ramachandran Krishna
Ravishankaran, Praveen
Ramshankar, Vijayalaksmi
Balkis Begum, Ahamed Sultan
Rangarajan, Gomadam Kuppuswamy
author_facet Krishnamurthy, Arvind
Kumar, Ramachandran Krishna
Ravishankaran, Praveen
Ramshankar, Vijayalaksmi
Balkis Begum, Ahamed Sultan
Rangarajan, Gomadam Kuppuswamy
author_sort Krishnamurthy, Arvind
collection PubMed
description BACKGROUND: Many radio-pharmaceuticals have been used over the years to localize the recurrences in patients with medullary carcinoma thyroid (MCT), including iodine-131-metaiodobenzylguanidine, thallium-201, technitium-99m dimercaptosuccinyl acid [Tc-99m DMSA (V)], Tc-99m methoxyisobutylisonitril, Tc-99 ethylenediamine diacetic acid/hydrazinonicotinyl-Tyr (3)-octreotide, and In-111 diethylenetriaminepenta-acetic acid-octreotide with varying sensitivities and specificities. AIMS: The aim of this study is to explore the role of Tc-99m DMSA (V) scan in MCT patients with postoperative persistent hypercalcitoninemia in the positron emission tomography-computerized tomography (PET-CT) era. MATERIALS AND METHODS: A retrospective review of 53 patients with proven sporadic MCT, who presented to our institution over a period 28 years from 1985 to 2012, was performed. Patients with persistently elevated levels of serum calcitonin (>150 pg/ml) were initially evaluated by a DMSA scan if conventional imaging failed to localize any focus of disease. RESULTS AND CONCLUSIONS: Our study showed that the postoperative levels of serum calcitonin significantly correlated with the overall survival of our patients and can possibly serve as a good prognostic marker. Tc-99m DMSA (V) scans demonstrated a sensitivity of 75%, specificity of 56%, a positive predictive value of 50%, and a negative predictive value of 80% in detecting metastasis in postoperative persistent hypercalcitoninemia. Our study showed that Tc-99m DMSA (V) scanning is an affordable and a reasonably sensitive imaging agent for localization of recurrent/metastatic disease. PET-CT seems to be a useful complementary tool and needs to be kept in the armamentarium for diagnosis of recurrence especially in cases of discordance between Tc-99m DMSA (V) scan and the serum calcitonin levels.
format Online
Article
Text
id pubmed-4157187
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-41571872014-09-10 Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography Krishnamurthy, Arvind Kumar, Ramachandran Krishna Ravishankaran, Praveen Ramshankar, Vijayalaksmi Balkis Begum, Ahamed Sultan Rangarajan, Gomadam Kuppuswamy Indian J Nucl Med Original Article BACKGROUND: Many radio-pharmaceuticals have been used over the years to localize the recurrences in patients with medullary carcinoma thyroid (MCT), including iodine-131-metaiodobenzylguanidine, thallium-201, technitium-99m dimercaptosuccinyl acid [Tc-99m DMSA (V)], Tc-99m methoxyisobutylisonitril, Tc-99 ethylenediamine diacetic acid/hydrazinonicotinyl-Tyr (3)-octreotide, and In-111 diethylenetriaminepenta-acetic acid-octreotide with varying sensitivities and specificities. AIMS: The aim of this study is to explore the role of Tc-99m DMSA (V) scan in MCT patients with postoperative persistent hypercalcitoninemia in the positron emission tomography-computerized tomography (PET-CT) era. MATERIALS AND METHODS: A retrospective review of 53 patients with proven sporadic MCT, who presented to our institution over a period 28 years from 1985 to 2012, was performed. Patients with persistently elevated levels of serum calcitonin (>150 pg/ml) were initially evaluated by a DMSA scan if conventional imaging failed to localize any focus of disease. RESULTS AND CONCLUSIONS: Our study showed that the postoperative levels of serum calcitonin significantly correlated with the overall survival of our patients and can possibly serve as a good prognostic marker. Tc-99m DMSA (V) scans demonstrated a sensitivity of 75%, specificity of 56%, a positive predictive value of 50%, and a negative predictive value of 80% in detecting metastasis in postoperative persistent hypercalcitoninemia. Our study showed that Tc-99m DMSA (V) scanning is an affordable and a reasonably sensitive imaging agent for localization of recurrent/metastatic disease. PET-CT seems to be a useful complementary tool and needs to be kept in the armamentarium for diagnosis of recurrence especially in cases of discordance between Tc-99m DMSA (V) scan and the serum calcitonin levels. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4157187/ /pubmed/25210279 http://dx.doi.org/10.4103/0972-3919.136562 Text en Copyright: © Indian Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Krishnamurthy, Arvind
Kumar, Ramachandran Krishna
Ravishankaran, Praveen
Ramshankar, Vijayalaksmi
Balkis Begum, Ahamed Sultan
Rangarajan, Gomadam Kuppuswamy
Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography
title Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography
title_full Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography
title_fullStr Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography
title_full_unstemmed Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography
title_short Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography
title_sort exploring the role of technitium-99m dimercaptosuccinyl acid (v) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157187/
https://www.ncbi.nlm.nih.gov/pubmed/25210279
http://dx.doi.org/10.4103/0972-3919.136562
work_keys_str_mv AT krishnamurthyarvind exploringtheroleoftechnitium99mdimercaptosuccinylacidvscaninmedullarycarcinomathyroidpatientswithpostoperativepersistenthypercalcitoninemiaintheeraofpositronemissiontomographycomputerizedtomography
AT kumarramachandrankrishna exploringtheroleoftechnitium99mdimercaptosuccinylacidvscaninmedullarycarcinomathyroidpatientswithpostoperativepersistenthypercalcitoninemiaintheeraofpositronemissiontomographycomputerizedtomography
AT ravishankaranpraveen exploringtheroleoftechnitium99mdimercaptosuccinylacidvscaninmedullarycarcinomathyroidpatientswithpostoperativepersistenthypercalcitoninemiaintheeraofpositronemissiontomographycomputerizedtomography
AT ramshankarvijayalaksmi exploringtheroleoftechnitium99mdimercaptosuccinylacidvscaninmedullarycarcinomathyroidpatientswithpostoperativepersistenthypercalcitoninemiaintheeraofpositronemissiontomographycomputerizedtomography
AT balkisbegumahamedsultan exploringtheroleoftechnitium99mdimercaptosuccinylacidvscaninmedullarycarcinomathyroidpatientswithpostoperativepersistenthypercalcitoninemiaintheeraofpositronemissiontomographycomputerizedtomography
AT rangarajangomadamkuppuswamy exploringtheroleoftechnitium99mdimercaptosuccinylacidvscaninmedullarycarcinomathyroidpatientswithpostoperativepersistenthypercalcitoninemiaintheeraofpositronemissiontomographycomputerizedtomography